Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Albrecht-Schgoer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|May 6, 2022
Cerebral Malaria: Current Clinical and Immunological AspectsKarin Albrecht-Schgoer, Peter Lackner, Erich Schmutzhard, et al.
Frontiers in Immunology|October 24, 2018
Regulation of Lymphatic GM-CSF Expression by the E3 Ubiquitin Ligase Cbl-bSebastian Peer, Giuseppe Cappellano, Natascha Hermann-Kleiter, et al.
Plos One|October 3, 2013
Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularizationWilfried Schgoer, Markus Theurl, Karin Albrecht-Schgoer, et al.
Angiogenesis|August 7, 2013
Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGFKarin Albrecht-Schgoer, Wilfried Schgoer, Markus Theurl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 20, 2018
Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathyMarkus Theurl, Daniela Lener, Karin Albrecht-Schgoer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 8, 2017
Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia modelKarin Albrecht-Schgoer, Jan Barthelmes, Wilfried Schgoer, et al.
Cell Communication and Signaling : CCS|July 29, 2016
Role of PKCtheta in macrophage-mediated immune response to Salmonella typhimurium infection in miceChrista Pfeifhofer-Obermair, Karin Albrecht-Schgoer, Sebastian Peer, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 12, 2013
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesisCan Tepeköylü, Feng-Sheng Wang, Radoslaw Kozaryn, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 21, 2014
Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart diseaseJohannes Holfeld, Daniel Zimpfer, Karin Albrecht-Schgoer, et al.
Cardiovascular Research|November 8, 2014
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosisMarkus Theurl, Wilfried Schgoer, Karin Albrecht-Schgoer, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|May 6, 2022
Cerebral Malaria: Current Clinical and Immunological AspectsKarin Albrecht-Schgoer, Peter Lackner, Erich Schmutzhard, et al.
Frontiers in Immunology|October 24, 2018
Regulation of Lymphatic GM-CSF Expression by the E3 Ubiquitin Ligase Cbl-bSebastian Peer, Giuseppe Cappellano, Natascha Hermann-Kleiter, et al.
Plos One|October 3, 2013
Secretoneurin gene therapy improves blood flow in an ischemia model in type 1 diabetic mice by enhancing therapeutic neovascularizationWilfried Schgoer, Markus Theurl, Karin Albrecht-Schgoer, et al.
Angiogenesis|August 7, 2013
Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGFKarin Albrecht-Schgoer, Wilfried Schgoer, Markus Theurl, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 20, 2018
Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathyMarkus Theurl, Daniela Lener, Karin Albrecht-Schgoer, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 8, 2017
Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia modelKarin Albrecht-Schgoer, Jan Barthelmes, Wilfried Schgoer, et al.
Cell Communication and Signaling : CCS|July 29, 2016
Role of PKCtheta in macrophage-mediated immune response to Salmonella typhimurium infection in miceChrista Pfeifhofer-Obermair, Karin Albrecht-Schgoer, Sebastian Peer, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 12, 2013
Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: implications for angiogenesis and vasculogenesisCan Tepeköylü, Feng-Sheng Wang, Radoslaw Kozaryn, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 21, 2014
Epicardial shock-wave therapy improves ventricular function in a porcine model of ischaemic heart diseaseJohannes Holfeld, Daniel Zimpfer, Karin Albrecht-Schgoer, et al.
Cardiovascular Research|November 8, 2014
Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E⁻/⁻ mice without influencing systemic atherosclerosisMarkus Theurl, Wilfried Schgoer, Karin Albrecht-Schgoer, et al.
Pageof 2